ANTAEA Supports Rare Disease Patients and Orphan Drug Development As a CRO, although involved in all types of clinical trials for highly prevalent therapeutic indications, ANTAEA has been always seeking to support research related to unmet medical needs, especially in the area of rare diseases. Orphan drug development is extremelycostly, thus, the final medicinal products […]... Read more